Caffeine challenge and breath-holding duration in patients with panic disorder
Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO 2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks ind...
Gespeichert in:
Veröffentlicht in: | Progress in neuro-psychopharmacology & biological psychiatry 2009-02, Vol.33 (1), p.41-44 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 44 |
---|---|
container_issue | 1 |
container_start_page | 41 |
container_title | Progress in neuro-psychopharmacology & biological psychiatry |
container_volume | 33 |
creator | Masdrakis, Vasilios G. Markianos, Manolis Vaidakis, Nikolaos Papakostas, Yiannis G. Oulis, Panagiotis |
description | Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO
2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks induced by caffeine intake.
BH duration and state anxiety were assessed in 40 PD patients (12 males), both at baseline and after a 400-mg caffeine challenge test.
Patients panicking after caffeine administration (14 patients, 4 males) exhibited a significant reduction of their post-challenge BH duration, while no change of the BH duration was observed in non-panicking patients (26 patients, 8 males). Reduction in post-challenge BH duration was not related to higher anxiety levels – as reflected in the State–Trait Anxiety Inventory-State Form scores – independently of the occurrence of a panic attack. Panickers exhibited significantly lower baseline BH duration, compared to non-panickers.
Our findings indicate that in PD patients, caffeine-induced panic attacks are strongly associated with a significant reduction of BH duration at both pre- and post-challenge. Jointly, these findings suggest that in a subgroup of PD patients, sensitivity to endogenous CO
2 accumulation may underlie both the lower BH durations and the caffeine-induced panic attacks. In this subgroup of PD patients, caffeine might exert its panicogenic properties through the exacerbation of patients' already pathological hypersensitivity to CO
2 accumulation, as indicated by both the significant decrease of their BH duration at post-challenge and by their significantly lower baseline BH duration respectively. |
doi_str_mv | 10.1016/j.pnpbp.2008.10.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20394388</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584608003084</els_id><sourcerecordid>20394388</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-d36832446acd2d544bc90edcccbeb4e0e067c42b704da98d6b1a46fc45fecf9a3</originalsourceid><addsrcrecordid>eNp9kE1v2zAMhoWhxZpm-wUDBl-6m1PqI7Z82KEIurVA0F66syBTdKPAkT3JWdF_X2UJ1ttOJF88JIiHsS8cFhx4db1djGFsx4UA0DlZAIgPbMZ1rUsleHXGZiByv9SqumCXKW0BgEuQH9kF142Euq5n7GFlu458oAI3tu8pPFNhgyvaSHbalJuhdz48F24f7eSHUPhQjLmjMKXixU-bPAWPhfNpiI7iJ3be2T7R51Ods18_bp9Wd-X68ef96mZdouJ6Kp2stBRKVRadcEulWmyAHCK21CoCgqpGJdoalLONdlXLrao6VMuOsGusnLNvx7tjHH7vKU1m5xNS39tAwz4ZAbJRUusMyiOIcUgpUmfG6Hc2vhoO5qDRbM1fjeag8RBmjXnr6-n8vt2Re985ecvA1QmwCW3fRRvQp3-c4FzUdX5izr4fOcoy_niKJmGWh-R8JJyMG_x_H3kDbWuS-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20394388</pqid></control><display><type>article</type><title>Caffeine challenge and breath-holding duration in patients with panic disorder</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Masdrakis, Vasilios G. ; Markianos, Manolis ; Vaidakis, Nikolaos ; Papakostas, Yiannis G. ; Oulis, Panagiotis</creator><creatorcontrib>Masdrakis, Vasilios G. ; Markianos, Manolis ; Vaidakis, Nikolaos ; Papakostas, Yiannis G. ; Oulis, Panagiotis</creatorcontrib><description>Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO
2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks induced by caffeine intake.
BH duration and state anxiety were assessed in 40 PD patients (12 males), both at baseline and after a 400-mg caffeine challenge test.
Patients panicking after caffeine administration (14 patients, 4 males) exhibited a significant reduction of their post-challenge BH duration, while no change of the BH duration was observed in non-panicking patients (26 patients, 8 males). Reduction in post-challenge BH duration was not related to higher anxiety levels – as reflected in the State–Trait Anxiety Inventory-State Form scores – independently of the occurrence of a panic attack. Panickers exhibited significantly lower baseline BH duration, compared to non-panickers.
Our findings indicate that in PD patients, caffeine-induced panic attacks are strongly associated with a significant reduction of BH duration at both pre- and post-challenge. Jointly, these findings suggest that in a subgroup of PD patients, sensitivity to endogenous CO
2 accumulation may underlie both the lower BH durations and the caffeine-induced panic attacks. In this subgroup of PD patients, caffeine might exert its panicogenic properties through the exacerbation of patients' already pathological hypersensitivity to CO
2 accumulation, as indicated by both the significant decrease of their BH duration at post-challenge and by their significantly lower baseline BH duration respectively.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2008.10.002</identifier><identifier>PMID: 18930777</identifier><identifier>CODEN: PNPPD7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adult ; Adult and adolescent clinical studies ; Anxiety disorders. Neuroses ; Asphyxia - metabolism ; Biological and medical sciences ; Breath-holding duration ; Caffeine - adverse effects ; Caffeine challenge test ; Carbon Dioxide - metabolism ; Female ; Humans ; Male ; Medical sciences ; Neuropharmacology ; Panic disorder ; Panic Disorder - chemically induced ; Panic Disorder - etiology ; Panic Disorder - physiopathology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Respiration</subject><ispartof>Progress in neuro-psychopharmacology & biological psychiatry, 2009-02, Vol.33 (1), p.41-44</ispartof><rights>2008 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-d36832446acd2d544bc90edcccbeb4e0e067c42b704da98d6b1a46fc45fecf9a3</citedby><cites>FETCH-LOGICAL-c418t-d36832446acd2d544bc90edcccbeb4e0e067c42b704da98d6b1a46fc45fecf9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pnpbp.2008.10.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21127720$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18930777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Masdrakis, Vasilios G.</creatorcontrib><creatorcontrib>Markianos, Manolis</creatorcontrib><creatorcontrib>Vaidakis, Nikolaos</creatorcontrib><creatorcontrib>Papakostas, Yiannis G.</creatorcontrib><creatorcontrib>Oulis, Panagiotis</creatorcontrib><title>Caffeine challenge and breath-holding duration in patients with panic disorder</title><title>Progress in neuro-psychopharmacology & biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO
2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks induced by caffeine intake.
BH duration and state anxiety were assessed in 40 PD patients (12 males), both at baseline and after a 400-mg caffeine challenge test.
Patients panicking after caffeine administration (14 patients, 4 males) exhibited a significant reduction of their post-challenge BH duration, while no change of the BH duration was observed in non-panicking patients (26 patients, 8 males). Reduction in post-challenge BH duration was not related to higher anxiety levels – as reflected in the State–Trait Anxiety Inventory-State Form scores – independently of the occurrence of a panic attack. Panickers exhibited significantly lower baseline BH duration, compared to non-panickers.
Our findings indicate that in PD patients, caffeine-induced panic attacks are strongly associated with a significant reduction of BH duration at both pre- and post-challenge. Jointly, these findings suggest that in a subgroup of PD patients, sensitivity to endogenous CO
2 accumulation may underlie both the lower BH durations and the caffeine-induced panic attacks. In this subgroup of PD patients, caffeine might exert its panicogenic properties through the exacerbation of patients' already pathological hypersensitivity to CO
2 accumulation, as indicated by both the significant decrease of their BH duration at post-challenge and by their significantly lower baseline BH duration respectively.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Anxiety disorders. Neuroses</subject><subject>Asphyxia - metabolism</subject><subject>Biological and medical sciences</subject><subject>Breath-holding duration</subject><subject>Caffeine - adverse effects</subject><subject>Caffeine challenge test</subject><subject>Carbon Dioxide - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Panic disorder</subject><subject>Panic Disorder - chemically induced</subject><subject>Panic Disorder - etiology</subject><subject>Panic Disorder - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Respiration</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v2zAMhoWhxZpm-wUDBl-6m1PqI7Z82KEIurVA0F66syBTdKPAkT3JWdF_X2UJ1ttOJF88JIiHsS8cFhx4db1djGFsx4UA0DlZAIgPbMZ1rUsleHXGZiByv9SqumCXKW0BgEuQH9kF142Euq5n7GFlu458oAI3tu8pPFNhgyvaSHbalJuhdz48F24f7eSHUPhQjLmjMKXixU-bPAWPhfNpiI7iJ3be2T7R51Ods18_bp9Wd-X68ef96mZdouJ6Kp2stBRKVRadcEulWmyAHCK21CoCgqpGJdoalLONdlXLrao6VMuOsGusnLNvx7tjHH7vKU1m5xNS39tAwz4ZAbJRUusMyiOIcUgpUmfG6Hc2vhoO5qDRbM1fjeag8RBmjXnr6-n8vt2Re985ecvA1QmwCW3fRRvQp3-c4FzUdX5izr4fOcoy_niKJmGWh-R8JJyMG_x_H3kDbWuS-A</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Masdrakis, Vasilios G.</creator><creator>Markianos, Manolis</creator><creator>Vaidakis, Nikolaos</creator><creator>Papakostas, Yiannis G.</creator><creator>Oulis, Panagiotis</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20090201</creationdate><title>Caffeine challenge and breath-holding duration in patients with panic disorder</title><author>Masdrakis, Vasilios G. ; Markianos, Manolis ; Vaidakis, Nikolaos ; Papakostas, Yiannis G. ; Oulis, Panagiotis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-d36832446acd2d544bc90edcccbeb4e0e067c42b704da98d6b1a46fc45fecf9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Anxiety disorders. Neuroses</topic><topic>Asphyxia - metabolism</topic><topic>Biological and medical sciences</topic><topic>Breath-holding duration</topic><topic>Caffeine - adverse effects</topic><topic>Caffeine challenge test</topic><topic>Carbon Dioxide - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Panic disorder</topic><topic>Panic Disorder - chemically induced</topic><topic>Panic Disorder - etiology</topic><topic>Panic Disorder - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Respiration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masdrakis, Vasilios G.</creatorcontrib><creatorcontrib>Markianos, Manolis</creatorcontrib><creatorcontrib>Vaidakis, Nikolaos</creatorcontrib><creatorcontrib>Papakostas, Yiannis G.</creatorcontrib><creatorcontrib>Oulis, Panagiotis</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masdrakis, Vasilios G.</au><au>Markianos, Manolis</au><au>Vaidakis, Nikolaos</au><au>Papakostas, Yiannis G.</au><au>Oulis, Panagiotis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caffeine challenge and breath-holding duration in patients with panic disorder</atitle><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2009-02-01</date><risdate>2009</risdate><volume>33</volume><issue>1</issue><spage>41</spage><epage>44</epage><pages>41-44</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><coden>PNPPD7</coden><abstract>Breath-holding (BH) has been used as a simple probe to increase endogenous carbon dioxide (CO
2). In patients with Panic Disorder (PD), lower baseline BH duration is associated with caffeine-induced panic attacks. In this paper, we assessed BH duration in PD patients in relation to panic attacks induced by caffeine intake.
BH duration and state anxiety were assessed in 40 PD patients (12 males), both at baseline and after a 400-mg caffeine challenge test.
Patients panicking after caffeine administration (14 patients, 4 males) exhibited a significant reduction of their post-challenge BH duration, while no change of the BH duration was observed in non-panicking patients (26 patients, 8 males). Reduction in post-challenge BH duration was not related to higher anxiety levels – as reflected in the State–Trait Anxiety Inventory-State Form scores – independently of the occurrence of a panic attack. Panickers exhibited significantly lower baseline BH duration, compared to non-panickers.
Our findings indicate that in PD patients, caffeine-induced panic attacks are strongly associated with a significant reduction of BH duration at both pre- and post-challenge. Jointly, these findings suggest that in a subgroup of PD patients, sensitivity to endogenous CO
2 accumulation may underlie both the lower BH durations and the caffeine-induced panic attacks. In this subgroup of PD patients, caffeine might exert its panicogenic properties through the exacerbation of patients' already pathological hypersensitivity to CO
2 accumulation, as indicated by both the significant decrease of their BH duration at post-challenge and by their significantly lower baseline BH duration respectively.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>18930777</pmid><doi>10.1016/j.pnpbp.2008.10.002</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-5846 |
ispartof | Progress in neuro-psychopharmacology & biological psychiatry, 2009-02, Vol.33 (1), p.41-44 |
issn | 0278-5846 1878-4216 |
language | eng |
recordid | cdi_proquest_miscellaneous_20394388 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adult Adult and adolescent clinical studies Anxiety disorders. Neuroses Asphyxia - metabolism Biological and medical sciences Breath-holding duration Caffeine - adverse effects Caffeine challenge test Carbon Dioxide - metabolism Female Humans Male Medical sciences Neuropharmacology Panic disorder Panic Disorder - chemically induced Panic Disorder - etiology Panic Disorder - physiopathology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Respiration |
title | Caffeine challenge and breath-holding duration in patients with panic disorder |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A14%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caffeine%20challenge%20and%20breath-holding%20duration%20in%20patients%20with%20panic%20disorder&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Masdrakis,%20Vasilios%20G.&rft.date=2009-02-01&rft.volume=33&rft.issue=1&rft.spage=41&rft.epage=44&rft.pages=41-44&rft.issn=0278-5846&rft.eissn=1878-4216&rft.coden=PNPPD7&rft_id=info:doi/10.1016/j.pnpbp.2008.10.002&rft_dat=%3Cproquest_cross%3E20394388%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20394388&rft_id=info:pmid/18930777&rft_els_id=S0278584608003084&rfr_iscdi=true |